Fund Holdings — REGENERON PHARMACEUTICALS, INC.

Total Portfolio Value
$177.22M
Total Bought
$114.56M
Total Sold
$412.1K
Net Transaction
+$114.15M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Parabilis Medicines, Inc.04,166,666+4,166,6660114,04264.35%+114,042
Intellia Therapeutics, Inc.(NTLA)3,702,9953,702,995047,47262,65535.35%+15,182
Adicet Bio, Inc.060,511+60,51105230.30%+523
Adicet Bio, Inc.60,5110-60,5114120—-412
Page 1 of 1
REGENERON PHARMACEUTICALS, INC. — 13F Holdings — Q2 2026 | TickerTrail